In the present study, we found that CD147 expression was upregulated in circulating platelets and leukocytes after stroke, and αCD147 treatment significantly decreased the levels of circulating platelet-leukocyte aggregates, which likely contribute to reduced lung leukocyte infiltration after stroke. Here, BSG is linked to stroke disorder.